Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v14-FR Version v2-FR
Language French French
Date Updated 2024-02-01 2023-05-26
Drug Identification Number 02422336 02422336
Brand name SUCCINYLCHOLINE CHLORIDE INJECTION USP SUCCINYLCHOLINE CHLORIDE INJECTION USP
Common or Proper name SUCCINYLCHOLINE CHLORIDE INJECTION USP SUCCINYLCHOLINE CHLORIDE INJECTION USP
Company Name HIKMA CANADA LIMITED HIKMA CANADA LIMITED
Ingredients SUCCINYLCHOLINE CHLORIDE SUCCINYLCHOLINE CHLORIDE
Strength(s) 20MG 20MG
Dosage form(s) SOLUTION SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS INTRAVENOUS INTRAVENOUS
Packaging size 20mL 20mL
ATC code M03AB M03AB
ATC description MUSCLE RELAXANTS, PERIPHERALLY ACTING AGENTS MUSCLE RELAXANTS, PERIPHERALLY ACTING AGENTS
Reason for shortage Demand increase for the drug. Demand increase for the drug.
Anticipated start date
Actual start date 2023-05-26 2023-05-26
Estimated end date 2024-01-31 2023-07-31
Actual end date 2024-01-31
Shortage status Resolved Anticipated shortage
Tier 3 Status No No
Company comments
Health Canada comments